Founder and CEO
Chris Velis is an entrepreneur and venture capitalist who has pioneered some of the most innovative medical technologies brought to market in the last decades. As Executive Chairman of Miraki Innovation, Chris forecasts imminent global health and medical challenges, uncovers technologies at leading academic and research institutions and U.S. government agencies and assembles teams of industry experts to solve these global problems. His leadership is integral to the success of the fund and each portfolio company. His management not only offers investments guidance and critical research and industry connections, but also helps guide each portfolio company along the fund’s proven, proprietary process that reduces new venture risk and enhances returns.
Since 2007, the companies Chris founded generated an estimated $6.36 billion in investor value on total investment of approximately $863 million. The most recent example is Auris Health, recognized by CNBC as one of the 50 most disruptive companies in the world. On Feb. 13, 2019 Johnson & Johnson announced that it is acquiring Auris Health for $5.75 billion in the largest venture-funded buyout in history. The Auris transaction is proceeded by a number of ventures by Chris that set the standard for motion preservation of the spine, regeneration of cartilage and soft tissue through the use of novel peptides, tissue regeneration using DNA pairs, stem cell and PRP technologies for use in regenerative medicine. Throughout his 27-year career, Chris has represented more than 150 medical device companies in a variety of business transactions including licensing agreements, joint venture partnerships, M&A and exit strategies.
Chris began his career at Merrill Lynch in corporate finance. In 1999, he was recruited to Brown Brothers Harriman (BBH) where he restructured the Investment Banking Division and oversaw a variety of industry-leading healthcare deals. Following BBH, Chris joined HealthpointCapital as partner and board member and was instrumental in the initial success of the $400 million healthcare fund.
Chris has been a speaker at global events such as China’s Chengdu Global Innovation and Entrepreneurship fair and Dubai’s Innovation Week. Chris graduated from the University of Massachusetts Amherst with a Bachelor of Arts in Economics and earned a Master of Business from the Boston University Questrom School of Business.